MAP3K7 and familial pancreatic carcinoma: GSK-3 can stabilize transforming growth factor beta-activated kinase 1 [(TAK1) a.k.a mitogen-activated protein kinase kinase kinase 7 (MAP3K7)] which plays a key role in pancreatic cancer.